Free preview
MD Pharmacology NMC syllabus ~5 min read Recent advances last updated on 2026-07-01

Penicillins and Cell-Wall-Synthesis Inhibitors

β-Lactams, Glycopeptides & Non-β-Lactam Wall Agents — Mechanism, Resistance & Clinical Use

Past RGUHS + DNB + MPMSU + MUHS · 12 RGUHSSep '25 MPMSUJan '25 RGUHSJun '24 MUHSWinter '23 MUHSSummer '21 DNBDec '21 RGUHSJun '16 MPMSU2016 DNBDec '12 MPMSU2011 MPMSU2011 RGUHSMay '10

Introduction

  • Cell-wall-synthesis inhibitors block assembly of the bacterial peptidoglycan (murein) wall — the rigid heteropolymer that resists the cell's high internal osmotic pressure; peptidoglycan and its D-alanine chemistry are unique to bacteria, giving these drugs their selective toxicity.
  • The β-lactam antibiotics — penicillins, cephalosporins, carbapenems and the monobactam aztreonam — share a β-lactam ring and a common mechanism (inhibition of peptidoglycan cross-linking); they are the single most important antibacterial class.
  • Non-β-lactam wall/membrane agents covered here: glycopeptides (vancomycin, teicoplanin), lipoglycopeptides (telavancin, dalbavancin, oritavancin), the lipopeptide daptomycin, and bacitracin.
  • Prototype natural penicillin = benzylpenicillin (penicillin G), discovered 1941; near-nontoxic to humans (up to 20 MU/day without organ toxicity).
  • Cephalosporins are a separate topic and appear here only in overview for β-lactam-family completeness.
Continue reading

Penicillins

PharmaNotes Pro · LAQ

Sign in with your Google account. If you're already subscribed, the chapter unlocks immediately — otherwise, pick Monthly or Annual on the next step.